Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

Market Cap	3.36B
Revenue (ttm)	474.19M
Net Income (ttm)	120.39M
Shares Out	148.95M
EPS (ttm)	0.80
PE Ratio	28.33
Forward PE	n/a
Dividend	0.11 (0.51%)
Ex-Dividend Date	May 20, 2025

Volume	6,761,415
Average Volume	6,988,655
Open	22.04
Previous Close	23.13
Day's Range	22.04 - 23.51
52-Week Range	14.50 - 27.56
Beta	1.00
RSI	55.45
Earnings Date	Aug 22, 2025

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China. The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant. It also provides chemical product for intermediates and food additives. Zhejiang Haisen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Dongyang, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1998
• Employees: 663
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 001367

Financial Performance

In 2024, SHE:001367's revenue was 471.51 million, an increase of 18.63% compared to the previous year's 397.45 million. Earnings were 122.56 million, an increase of 17.09%.